ad

Ajanta Pharma Ltd. (AJANTPHARM) Share Price Hits Fresh 52-Week High

18 Aug 20261:29 pm

Ajanta Pharma Ltd. (AJANTPHARM) Share Price Hits Fresh 52-Week High

Ajanta Pharma Ltd. Share Price stood at Rs 3,725, up 0.32% today, after hitting a fresh 52-week high of Rs 3,796.95. Market capitalisation stood at Rs 45,924.32 crore.

Ajanta Pharma Ltd. Share Price was at Rs 3,725 on 18 August 2026 at 12:45 PM IST, up Rs 11.9 or 0.32% from the previous close of Rs 3,713.1, after touching a fresh 52-week high of Rs 3,796.95 during the session. The company’s market capitalisation stood at Rs 45,924.32 crore, putting the stock firmly on the radar of investors tracking 52 Week High Stocks, Market Movers and Stocks in News.

This Ajanta Pharma Ltd. Share Price Today move matters because the supplied data confirms a clear price event: a new one-year high, a strong intraday range between Rs 3,709.1 and Rs 3,796.95, and turnover of Rs 1.24 crore. At the same time, the verified data does not establish a company-specific catalyst behind the rise. That makes the stock relevant more for its price action and valuation context than for any confirmed corporate trigger in today’s Ajanta Pharma Ltd. Stock News.

For readers following Ajanta Pharma Ltd. Share Price Live, the key points are straightforward. The stock opened at Rs 3,713.5, traded slightly below the day’s peak by midday, and still held above the previous close. Univest views this as an event-led Share Price Update: the fresh 52-week peak is confirmed, the move is modest in percentage terms, and the next step is to examine whether the underlying Fundamental Analysis and sector positioning support the market’s attention.

Ajanta Pharma Ltd. Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 3,725
Previous Close Rs 3,713.1
Today's Change +Rs 11.9 (+0.32%)
Day Open Rs 3,713.5
Fresh 52-Week High Rs 3,796.95
Day Low Rs 3,709.1
Current Volume 3,318
Turnover Rs 1.24 crore
Market Capitalisation Rs 45,924.32 crore

Ajanta Pharma Ltd. (AJANTPHARM) traded at Rs 3,725. versus the previous close of Rs 3,713.1, a rise of 0.32%. The stock opened at Rs 3,713.5, reached Rs 3,796.95, touched Rs 3,709.1. Reported volume was 3,318.

Ajanta Pharma Ltd. Share Price Today reflects a confirmed breakout to a fresh yearly high, with the stock touching Rs 3,796.95 before trading at Rs 3,725. The session shows a positive day-on-day move, a narrow gain versus the previous close, and active intraday price movement within a broad range.

The stock opened at Rs 3,713.5 against a previous close of Rs 3,713.1, indicating a near-flat start before moving higher through the day. It then hit its 52-week high of Rs 3,796.95 and later traded at Rs 3,725, still above the previous close. The day’s low stood at Rs 3,709.1, which means the intraday range was Rs 87.85 between low and high. That is notable for traders watching Price Action and intraday volatility within the Indian Stock Market.

In absolute terms, the gain of Rs 11.9 looks contained, but the fact that the stock marked a fresh 52-week peak changes the significance of the move. A new one-year high often places a stock on momentum screens and fresh watchlists, even when the day’s percentage move remains moderate. This is one reason Ajanta Pharma Ltd. Share News may attract attention in Stock Market Today and Share Market Today discussions.

Turnover stood at Rs 1.24 crore, while current volume was 3,318 shares at the time captured in the supplied data. That indicates activity, although the present dataset does not tie the move to any confirmed volume benchmark or corporate development. In Univest’s reading, this keeps the focus on the price event itself: Ajanta Pharma Ltd. Share Price has entered a new 52-week zone, which naturally leads investors to test that move against valuation and financial efficiency metrics.

Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis

Metric Value
Market Capitalisation Rs 45,924.32 crore
P/E Ratio 170.32x
P/B Ratio 0.42x
ROE -2.89%
ROCE -0.26%

Ajanta Pharma Ltd. was valued at a P/E ratio of 170.32x, a P/B ratio of 0.42x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric Value
Sector Healthcare
Benchmark Scope same sector
Company P/E Ratio 170.32x
Benchmark Median P/E 21x
Benchmark Average P/E 49.19x
Benchmark P/E Range 0x to 1,598.54x
Company P/B Ratio 0.42x
Benchmark Median P/B 1.9x
Company ROE -2.89%
Benchmark Median ROE 10.92%
Company ROCE -0.26%
Benchmark Median ROCE 13.29%
Company Market Capitalisation Rs 45,924.32 crore
Benchmark Median Market Cap Rs 136.28 crore

Ajanta Pharma Ltd. (AJANTPHARM) is classified under sector: Healthcare.

Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 170.32x, which is above the benchmark median of 21x, a difference of +711.05%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Dishman Carbogen Amcis Ltd. DCAL 2,985.15 170.32 0.42 -2.89 -0.26
Beta Drugs Ltd. BETA 2,827.67 65.02 10.29 18.65 22.17
Ind-Swift Laboratories Ltd. INDSWFTLAB 2,645.37 47.53 1.82 -0.78 8.31
Dr Agarwals Eye Hospital Ltd. DRAGARWQ 2,562.17 33.62 6.93 -2.6 16.92
Fredun Pharmaceuticals Ltd. FREDUN 2,559.68 54.85 8.19 11.42 13.15

Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 170.32x compared with the displayed peer median of 54.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 45,924.32 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Ajanta Pharma Ltd.

The stock is being watched for a specific set of verified reasons visible in the supplied data rather than any unconfirmed catalyst.

  • Fresh price event: Ajanta Pharma Ltd. Share Price hit a new 52-week high of Rs 3,796.95 and was trading at Rs 3,725, up 0.32% on the day.
  • Intraday movement: The stock moved between Rs 3,709.1 and Rs 3,796.95 after opening at Rs 3,713.5, making it relevant for Price Action and Stock Performance tracking.
  • Large market value: Market capitalisation stood at Rs 45,924.32 crore, which keeps the stock visible in daily Share Price News and Company News screens.
  • Valuation debate: The P/E Ratio of 170.32 is above healthcare benchmark levels, while the P/B Ratio of 0.42 is below sector averages.
  • Profitability watch: ROE at -2.89% and ROCE at -0.26% make the fresh high worth monitoring against financial efficiency metrics.
  • Sector context: The stock sits within Healthcare, where the benchmark covers 196 companies and offers a broad comparison base for valuation and returns.

About Ajanta Pharma Ltd.

Ajanta Pharma Ltd. is identified in the supplied dataset as a listed company tracked under the Healthcare sector. The stock trades under the symbol AJANTPHARM, and the current event being discussed is a fresh 52-week high recorded on 18 August 2026. In today’s Ajanta Pharma Ltd. Latest News flow, the verified information centres on market data, valuation measures and sector positioning rather than on a separately supplied business update.

The company is being evaluated here through its live market metrics, including Share Price, Market Cap, P/E Ratio, P/B Ratio, ROE and ROCE, and through its comparison with a set of healthcare peers and sector benchmarks. That means the current Ajanta Pharma Ltd. Stock News is especially relevant for investors who track NSE and BSE-listed Healthcare names through quantitative screens. On Univest, such coverage helps connect a one-year high event with broader stock analysis, peer comparison and sector context without stretching beyond the verified data available for this update.

Track Ajanta Pharma Ltd. Share Price on Univest

Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors following Ajanta Pharma Ltd. Share Price can use Univest to track live share price moves, 52-week levels, market capitalisation, valuation ratios, peer positioning and sector context in one place. That makes it easier to follow Ajanta Pharma Ltd. Share Price Today alongside broader stock performance trends.

Univest also helps users monitor metrics such as P/E Ratio, P/B Ratio, ROE, ROCE, market movements and fresh price events like a yearly high or 52-week peak. For readers looking beyond a single session’s Ajanta Pharma Ltd. Share Price Update, Univest provides a structured way to watch Shareholding Pattern data when available, benchmark comparisons and continuing Stock News coverage.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is the current Ajanta Pharma Ltd. Share Price?

Ans. Ajanta Pharma Ltd. Share Price was Rs 3,725 at 12:45 PM IST on 18 August 2026. The stock was up Rs 11.9, or 0.32%, from the previous close of Rs 3,713.1 in today’s session.

What is the fresh 52-week high for Ajanta Pharma Ltd. Share Price?

Ans. The fresh 52-week high for Ajanta Pharma Ltd. Share Price is Rs 3,796.95. The stock touched that level during the session before trading at Rs 3,725, which still kept it above the previous close.

Why is Ajanta Pharma Ltd. Share Price rising today?

Ans. The supplied data confirms that Ajanta Pharma Ltd. Share Price rose 0.32% and hit a fresh one-year high today. However, the verified dataset establishes the price event itself and does not identify a company-specific catalyst.

How much did Ajanta Pharma Ltd. Share Price gain today?

Ans. Ajanta Pharma Ltd. Share Price gained Rs 11.9 on the day, which translates into a 0.32% rise over the previous close of Rs 3,713.1. The move coincided with a fresh 52-week high of Rs 3,796.95.

What was the intraday range for Ajanta Pharma Ltd. Share Price Today?

Ans. Ajanta Pharma Ltd. Share Price Today traded between Rs 3,709.1 and Rs 3,796.95. The stock opened at Rs 3,713.5, hit a fresh yearly high, and was later seen trading at Rs 3,725 in the session.

What is the market capitalisation of Ajanta Pharma Ltd.?

Ans. Ajanta Pharma Ltd. had a market capitalisation of Rs 45,924.32 crore in the supplied data. That makes it significantly larger than the healthcare sector benchmark average market capitalisation of Rs 468.36 crore shown in this analysis.

Is Ajanta Pharma Ltd. Share Price expensive on P/E basis?

Ans. Ajanta Pharma Ltd. Share Price is trading at a P/E Ratio of 170.32. That is above the healthcare sector median of 21 and average of 49.19, indicating a higher valuation on this metric versus the supplied benchmark.

How does Ajanta Pharma Ltd. compare on price-to-book ratio?

Ans. Ajanta Pharma Ltd. has a P/B Ratio of 0.42. That is below the healthcare sector median of 1.9 and average of 2.6, so the stock screens lower than the benchmark on price-to-book terms.

What do ROE and ROCE show for Ajanta Pharma Ltd.?

Ans. Ajanta Pharma Ltd. shows ROE of -2.89% and ROCE of -0.26% in the supplied figures. Both are below the healthcare sector medians of 10.92% for ROE and 13.29% for ROCE.

How does Ajanta Pharma Ltd. compare with healthcare peers?

Ans. Ajanta Pharma Ltd. has a market capitalisation of Rs 45,924.32 crore, much higher than the listed peers supplied. Its P/E of 170.32 is also above most peers, while its ROE and ROCE are weaker than several of them.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down